Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink.

Gee J, Naleway A, Shui I, Baggs J, Yin R, Li R, Kulldorff M, Lewis E, Fireman B, Daley MF, Klein NP, Weintraub ES.

Vaccine. 2011 Oct 26;29(46):8279-84. doi: 10.1016/j.vaccine.2011.08.106. Epub 2011 Sep 9.

PMID:
21907257
2.

An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015.

Vichnin M, Bonanni P, Klein NP, Garland SM, Block SL, Kjaer SK, Sings HL, Perez G, Haupt RM, Saah AJ, Lievano F, Velicer C, Drury R, Kuter BJ.

Pediatr Infect Dis J. 2015 Sep;34(9):983-91. doi: 10.1097/INF.0000000000000793. Review.

PMID:
26107345
3.

Post-licensure safety surveillance for human papillomavirus-16/18-AS04-adjuvanted vaccine: more than 4 years of experience.

Angelo MG, Zima J, Tavares Da Silva F, Baril L, Arellano F.

Pharmacoepidemiol Drug Saf. 2014 May;23(5):456-65. doi: 10.1002/pds.3593. Epub 2014 Feb 20. Review.

4.

Allergic reactions to Japanese encephalitis vaccine.

Plesner AM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. Review. Erratum in: Immunol Allergy Clin North Am. 2004 May;24(2):335.

PMID:
14753386
5.

Safety of human papillomavirus vaccines: a review.

Stillo M, Carrillo Santisteve P, Lopalco PL.

Expert Opin Drug Saf. 2015 May;14(5):697-712. doi: 10.1517/14740338.2015.1013532. Epub 2015 Feb 18. Review.

6.

Safety of the HPV Bivalent and Quadrivalent Vaccines During Pregnancy.

Forinash AB, Yancey AM, Pitlick JM, Myles TD.

Ann Pharmacother. 2011 Feb;45(2):258-62. doi: 10.1345/aph.1P396. Review.

PMID:
21285408
7.

The Vaccine Safety Datalink: a model for monitoring immunization safety.

Baggs J, Gee J, Lewis E, Fowler G, Benson P, Lieu T, Naleway A, Klein NP, Baxter R, Belongia E, Glanz J, Hambidge SJ, Jacobsen SJ, Jackson L, Nordin J, Weintraub E.

Pediatrics. 2011 May;127 Suppl 1:S45-53. doi: 10.1542/peds.2010-1722H. Epub 2011 Apr 18. Review.

PMID:
21502240
9.

Post-licensure monitoring of HPV vaccine in the United States.

Markowitz LE, Hariri S, Unger ER, Saraiya M, Datta SD, Dunne EF.

Vaccine. 2010 Jul 5;28(30):4731-7. doi: 10.1016/j.vaccine.2010.02.019. Epub 2010 Feb 25. Review.

PMID:
20188681
10.

Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics.

Pomfret TC, Gagnon JM Jr, Gilchrist AT.

J Clin Pharm Ther. 2011 Feb;36(1):1-9. doi: 10.1111/j.1365-2710.2009.01150.x. Review.

PMID:
21198715
11.

Safety of Human Papillomavirus 9-Valent Vaccine: A Meta-Analysis of Randomized Trials.

Costa APF, Cobucci RNO, da Silva JM, da Costa Lima PH, Giraldo PC, Gonçalves AK.

J Immunol Res. 2017;2017:3736201. doi: 10.1155/2017/3736201. Epub 2017 Jul 24. Review.

Supplemental Content

Support Center